Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Vaccines

  Free Subscription


Articles published in Science

Retrieve available abstracts of 106 articles:
HTML format



Single Articles


    December 2023
  1. MIGUELES SA, Nettere DM, Gavil NV, Wang LT, et al
    HIV vaccines induce CD8(+) T cells with low antigen receptor sensitivity.
    Science. 2023;382:1270-1276.
    PubMed     Abstract available


    November 2023
  2. COHEN J
    A chikungunya vaccine is likely to get approved. Who will get it?
    Science. 2023;382:503-504.
    PubMed     Abstract available


    October 2023
  3. WADMAN M
    First malaria vaccine slashes childhood deaths.
    Science. 2023;382:357.
    PubMed     Abstract available


  4. COHEN J
    Billions boost next-generation weapons against SARS-CoV-2.
    Science. 2023;382:359-360.
    PubMed     Abstract available


  5. KRAMMER F, Ellebedy AH
    Variant-adapted COVID-19 booster vaccines.
    Science. 2023;382:157-159.
    PubMed     Abstract available


  6. COUZIN-FRANKEL J
    New Novavax vaccine OK'd; studies size it up against mRNA.
    Science. 2023;382:141-142.
    PubMed     Abstract available


  7. VOGEL G
    Second malaria vaccine gets WHO green light.
    Science. 2023;382:16-17.
    PubMed     Abstract available


  8. OFFORD C, Cohen J
    Award honors pair for mRNA work key to COVID-19 vaccines.
    Science. 2023;382:22.
    PubMed     Abstract available


    September 2023
  9. GOLDMAN MA
    Pandemics and their lessonsForeign Bodies: Pandemics, Vaccines, and the Health of Nations Simon Schama Ecco, 2023. 480 pp.
    Science. 2023;381:1418.
    PubMed     Abstract available


    July 2023
  10. COHEN J
    Childhood vaccine crusader shares concerns for future.
    Science. 2023;381:365.
    PubMed     Abstract available


  11. VOGEL G, Couzin-Frankel J
    Studies probe COVID-19 shots' link to rare symptoms.
    Science. 2023;381:18-19.
    PubMed     Abstract available


    June 2023
  12. COHEN J
    Companies hoard COVID-19 vaccines, stalling future research.
    Science. 2023;380:1001-1002.
    PubMed     Abstract available


    May 2023
  13. COUZIN-FRANKEL J
    Decision nears for fall coronavirus vaccine.
    Science. 2023;380:784.
    PubMed     Abstract available


  14. LAVERY JV, Porter RM, Addiss DG
    Cascading failures in COVID-19 vaccine equity.
    Science. 2023;380:460-462.
    PubMed     Abstract available


    April 2023
  15. KAISER J
    Tailored melanoma vaccine may stave off cancer.
    Science. 2023;380:232.
    PubMed     Abstract available


  16. OFFERSGAARD A, Bukh J, Gottwein JM
    Toward a vaccine against hepatitis C virus.
    Science. 2023;380:37-38.
    PubMed     Abstract available


    March 2023
  17. CHUBATSU NUNES HH, Dang TT
    A booster for vaccines from plants.
    Science. 2023;379:1187-1188.
    PubMed     Abstract available


  18. VOGEL G
    Do COVID-19 vaccine mandates still make sense?
    Science. 2023;379:1072-1073.
    PubMed     Abstract available


    February 2023
  19. NORMILE D
    Japan moves to bolster its vaccine R&D sector.
    Science. 2023;379:627.
    PubMed     Abstract available


  20. COUZIN-FRANKEL J
    New COVID-19 vaccine strategy would mimic flu's annual shots.
    Science. 2023;379:425-426.
    PubMed     Abstract available


    January 2023
  21. KALIA A, Hickman HD
    A vaccine sanctuary in the lymph node.
    Science. 2023;379:332-333.
    PubMed     Abstract available


    December 2022
  22. VOGEL G
    Pandemic vaccine equity plan may soon start winding down.
    Science. 2022;378:1158-1159.
    PubMed     Abstract available


  23. MOORE PL
    Triggering rare HIV antibodies by vaccination.
    Science. 2022;378:949-950.
    PubMed     Abstract available


  24. LEGGAT DJ, Cohen KW, Willis JR, Fulp WJ, et al
    Vaccination induces HIV broadly neutralizing antibody precursors in humans.
    Science. 2022;378:eadd6502.
    PubMed     Abstract available


  25. KUPFERSCHMIDT K
    Vaccines are in short supply amid global cholera surge.
    Science. 2022;378:938-939.
    PubMed     Abstract available


    November 2022
  26. KELVIN AA, Falzarano D
    The influenza universe in an mRNA vaccine.
    Science. 2022;378:827-828.
    PubMed     Abstract available


  27. AREVALO CP, Bolton MJ, Le Sage V, Ye N, et al
    A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes.
    Science. 2022;378:899-904.
    PubMed     Abstract available


  28. MALE V
    COVID-19 vaccination and menstruation.
    Science. 2022;378:704-706.
    PubMed     Abstract available


    October 2022
  29. COHEN J
    Forgotten Ebola vaccine could help in outbreak.
    Science. 2022;378:340-341.
    PubMed     Abstract available


  30. MAO T, Israelow B, Pena-Hernandez MA, Suberi A, et al
    Unadjuvanted intranasal spike vaccine elicits protective mucosal immunity against sarbecoviruses.
    Science. 2022 Oct 27:eabo2523. doi: 10.1126/science.abo2523.
    PubMed     Abstract available


  31. TORRENTS DE LA PENA A, Sliepen K, Eshun-Wilson L, Newby ML, et al
    Structure of the hepatitis C virus E1E2 glycoprotein complex.
    Science. 2022;378:263-269.
    PubMed     Abstract available


  32. COUZIN-FRANKEL J
    Heart risks fuel debate over COVID-19 boosters.
    Science. 2022;378:234-235.
    PubMed     Abstract available


  33. COHEN J
    Uganda's Ebola outbreak will put novel vaccines to the test.
    Science. 2022;378:14-15.
    PubMed     Abstract available


    September 2022
  34. VOGEL G
    New Omicron strains may portend big COVID-19 waves.
    Science. 2022;377:1479.
    PubMed     Abstract available


    August 2022
  35. WHERRY EJ, Barouch DH
    T cell immunity to COVID-19 vaccines.
    Science. 2022;377:821-822.
    PubMed     Abstract available


  36. KUPFERSCHMIDT K
    Scientists scramble to set up monkeypox vaccine trials.
    Science. 2022;377:696-697.
    PubMed     Abstract available


  37. COHEN J
    Making broader coronavirus vaccines is a struggle.
    Science. 2022;377:566-567.
    PubMed     Abstract available


    July 2022
  38. DOLGIN E
    The ascent of ModernaThe Messenger: Moderna, the Vaccine, and the Business Gamble That Changed the World Peter Loftus Harvard Business Review Press, 2022. 320 pp.
    Science. 2022;377:479.
    PubMed     Abstract available


  39. BOWEN JE, Addetia A, Dang HV, Stewart C, et al
    Omicron spike function and neutralizing activity elicited by a comprehensive panel of vaccines.
    Science. 2022 Jul 19:eabq0203. doi: 10.1126/science.abq0203.
    PubMed     Abstract available


  40. CHEN R, Guo X, Zhu A
    Vaccinate to combat COVID-19 in China.
    Science. 2022;377:271.
    PubMed    


  41. DACON C, Tucker C, Peng L, Lee CD, et al
    Broadly neutralizing antibodies target the coronavirus fusion peptide.
    Science. 2022 Jul 12:eabq3773. doi: 10.1126/science.abq3773.
    PubMed     Abstract available


    June 2022
  42. REYNOLDS CJ, Pade C, Gibbons JM, Otter AD, et al
    Immune boosting by B.1.1.529 (Omicron) depends on previous SARS-CoV-2 exposure.
    Science. 2022 Jun 14:eabq1841. doi: 10.1126/science.abq1841.
    PubMed     Abstract available


  43. KUPFERSCHMIDT K
    Monkeypox vaccination plans take shape amid questions.
    Science. 2022;376:1142-1143.
    PubMed     Abstract available


    May 2022
  44. STOKSTAD E
    Wrestling with bird flu, Europe considers once-taboo vaccines.
    Science. 2022;376:682-683.
    PubMed     Abstract available


  45. DOLGIN E
    Better lipids to power next generation of mRNA vaccines.
    Science. 2022;376:680-681.
    PubMed     Abstract available


  46. VOGEL G
    New subvariants are masters of immune evasion.
    Science. 2022;376:679-680.
    PubMed     Abstract available


    April 2022
  47. COHEN J
    First self-copying mRNA vaccine proves itself in pandemic trial.
    Science. 2022;376:446.
    PubMed     Abstract available


  48. PULLA P
    India's speedy vaccine approvals come under fire.
    Science. 2022;376:442-443.
    PubMed     Abstract available


  49. ARINAMINPATHY N, Saad-Roy CM, Yang Q, Ahmad I, et al
    A global system for the next generation of vaccines.
    Science. 2022;376:462-464.
    PubMed     Abstract available


  50. COUZIN-FRANKEL J
    Global project gears up to study vaccine safety.
    Science. 2022;376:227-228.
    PubMed     Abstract available


  51. COHEN J
    New crop of mRNA vaccines aim for accessibility.
    Science. 2022;376:120-121.
    PubMed     Abstract available


  52. NORMILE D
    Japan reboots HPV vaccination drive after 9-year gap.
    Science. 2022;376:14.
    PubMed     Abstract available


    March 2022
  53. LENTZOS F, Rybicki EP, Engelhard M, Paterson P, et al
    Self-spreading vaccines: Base policy on evidence-Response.
    Science. 2022;375:1363.
    PubMed    


  54. STREICKER DG, Bull JJ, Nuismer SL
    Self-spreading vaccines: Base policy on evidence.
    Science. 2022;375:1362-1363.
    PubMed    


  55. DEAN NE, Halloran ME
    Protecting the herd with vaccination.
    Science. 2022;375:1088-1089.
    PubMed     Abstract available


  56. ALTMANN DM, Boyton RJ
    COVID-19 vaccination: The road ahead.
    Science. 2022;375:1127-1132.
    PubMed     Abstract available


  57. EDWARDS AM, Baric RS, Saphire EO, Ulmer JB, et al
    Stopping pandemics before they start: Lessons learned from SARS-CoV-2.
    Science. 2022;375:1133-1139.
    PubMed     Abstract available


  58. KOELLE K, Martin MA, Antia R, Lopman B, et al
    The changing epidemiology of SARS-CoV-2.
    Science. 2022;375:1116-1121.
    PubMed     Abstract available


  59. MOBARAK AM, Miguel E, Abaluck J, Ahuja A, et al
    End COVID-19 in low- and middle-income countries.
    Science. 2022;375:1105-1110.
    PubMed    


  60. ROBERTS L
    Africa battles out-of-control polio outbreaks.
    Science. 2022;375:1079-1080.
    PubMed     Abstract available


    February 2022
  61. BIERING SB
    One antibody to treat them all.
    Science. 2022;375:803.
    PubMed     Abstract available


  62. ROURKE M, Eccleston-Turner M, Switzer S
    Sovereignty, sanctions, and data sharing under international law.
    Science. 2022;375:724-726.
    PubMed     Abstract available


  63. KAKU CI, Champney ER, Normark J, Garcia M, et al
    Broad anti-SARS-CoV-2 antibody immunity induced by heterologous ChAdOx1/mRNA-1273 vaccination.
    Science. 2022 Feb 10:eabn2688. doi: 10.1126/science.abn2688.
    PubMed     Abstract available


  64. ELLIOTT P, Bodinier B, Eales O, Wang H, et al
    Rapid increase in Omicron infections in England during December 2021: REACT-1 study.
    Science. 2022 Feb 8:eabn8347. doi: 10.1126/science.abn8347.
    PubMed     Abstract available


  65. WADMAN M
    New Omicron begins to take over, despite late start.
    Science. 2022;375:480-481.
    PubMed     Abstract available


    January 2022
  66. COUZIN-FRANKEL J, Vogel G
    Vaccines may cause rare, Long Covid-like symptoms.
    Science. 2022;375:364-366.
    PubMed     Abstract available


  67. KUPFERSCHMIDT K
    After Omicron, some scientists foresee 'a period of quiet'.
    Science. 2022;375:366-367.
    PubMed     Abstract available


  68. HAYEK S, Shaham G, Ben-Shlomo Y, Kepten E, et al
    Indirect protection of children from SARS-CoV-2 infection through parental vaccination.
    Science. 2022 Jan 27:eabm3087. doi: 10.1126/science.abm3087.
    PubMed     Abstract available


  69. PRUNAS O, Warren JL, Crawford FW, Gazit S, et al
    Vaccination with BNT162b2 reduces transmission of SARS-CoV-2 to household contacts in Israel.
    Science. 2022 Jan 27:eabl4292. doi: 10.1126/science.abl4292.
    PubMed     Abstract available


  70. WADMAN M
    Studies reveal dangers of SARS-CoV-2 infection in pregnancy.
    Science. 2022;375:253.
    PubMed     Abstract available


  71. MANNAR D, Saville JW, Zhu X, Srivastava SS, et al
    SARS-CoV-2 Omicron variant: Antibody evasion and cryo-EM structure of spike protein-ACE2 complex.
    Science. 2022 Jan 20:eabn7760. doi: 10.1126/science.abn7760.
    PubMed     Abstract available


  72. MUIK A, Lui BG, Wallisch AK, Bacher M, et al
    Neutralization of SARS-CoV-2 Omicron by BNT162b2 mRNA vaccine-elicited human sera.
    Science. 2022 Jan 18:eabn7591. doi: 10.1126/science.abn7591.
    PubMed     Abstract available


  73. KAISER J
    Study of soldiers implicates common virus as MS trigger.
    Science. 2022;375:133.
    PubMed     Abstract available


  74. OPENSHAW PJM
    Using correlates to accelerate vaccinology.
    Science. 2022;375:22-23.
    PubMed     Abstract available


  75. LENTZOS F, Rybicki EP, Engelhard M, Paterson P, et al
    Eroding norms over release of self-spreading viruses.
    Science. 2022;375:31-33.
    PubMed     Abstract available


  76. KUPFERSCHMIDT K, Vogel G
    Omicron threat remains fuzzy as cases explode.
    Science. 2022;375:9-10.
    PubMed     Abstract available


    December 2021
  77. GUPTA RK, Topol EJ
    COVID-19 vaccine breakthrough infections.
    Science. 2021;374:1561-1562.
    PubMed     Abstract available


  78. COHEN J
    Will global vaccine shortfalls end in 2022?
    Science. 2021;374:1546.
    PubMed     Abstract available


  79. COHEN J
    Omicron sparks a vaccine strategy debate.
    Science. 2021;374:1544-1545.
    PubMed     Abstract available


  80. VOGEL G, Kupferschmidt K
    Early lab studies shed light on Omicron's behavior.
    Science. 2021;374:1543-1544.
    PubMed     Abstract available


  81. CERNUSCHI T, Malvolti S, Downham M, Maugeais D, et al
    COVID-19 impact on infant and adolescent vaccine supplies.
    Science. 2021;374:1438-1441.
    PubMed     Abstract available


  82. KUPFERSCHMIDT K
    Missed shots.
    Science. 2021;374:1434-1435.
    PubMed     Abstract available


  83. KUPFERSCHMIDT K
    Scientists see a 'really, really tough winter' with Omicron.
    Science. 2021;374:1421-1422.
    PubMed     Abstract available


  84. KUPFERSCHMIDT K, Vogel G
    How bad is Omicron? Some clues are emerging.
    Science. 2021;374:1304-1305.
    PubMed     Abstract available


  85. KUPFERSCHMIDT K
    Where did 'weird' Omicron come from?
    Science. 2021;374:1179.
    PubMed    


  86. REYNOLDS CJ, Gibbons JM, Pade C, Lin KM, et al
    Heterologous infection and vaccination shapes immunity against SARS-CoV-2 variants.
    Science. 2021 Dec 2:eabm0811.
    PubMed     Abstract available


  87. NABEL KG, Clark SA, Shankar S, Pan J, et al
    Structural basis for continued antibody evasion by the SARS-CoV-2 receptor binding domain.
    Science. 2021 Dec 2:eabl6251.
    PubMed     Abstract available


    November 2021
  88. GILBERT PB, Montefiori DC, McDermott AB, Fong Y, et al
    Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial.
    Science. 2021 Nov 23:eab3435.
    PubMed     Abstract available


  89. WADMAN M
    To fight Lyme disease, vaccine targets ticks.
    Science. 2021;374:925.
    PubMed     Abstract available


  90. GERBER JS, Offit PA
    COVID-19 vaccines for children.
    Science. 2021;374:913.
    PubMed     Abstract available


  91. NORMILE D
    'Zero COVID' is getting harder-but China is sticking with it.
    Science. 2021;374:924.
    PubMed     Abstract available


  92. JECKER NS
    Cash incentives, ethics, and COVID-19 vaccination.
    Science. 2021;374:819-820.
    PubMed     Abstract available


  93. MCCALLUM M, Walls AC, Sprouse KR, Bowen JE, et al
    Molecular basis of immune evasion by the Delta and Kappa SARS-CoV-2 variants.
    Science. 2021 Nov 9:eabl8506. doi: 10.1126/science.abl8506.
    PubMed     Abstract available


  94. LADHANI SN
    Children and COVID-19 in schools.
    Science. 2021;374:680-682.
    PubMed     Abstract available


  95. COHN BA, Cirillo PM, Murphy CC, Krigbaum NY, et al
    SARS-CoV-2 vaccine protection and deaths among US veterans during 2021.
    Science. 2021 Nov 4:eabm0620. doi: 10.1126/science.abm0620.
    PubMed     Abstract available


  96. ELLIOTT P, Haw D, Wang H, Eales O, et al
    Exponential growth, high prevalence of SARS-CoV-2, and vaccine effectiveness associated with the Delta variant.
    Science. 2021 Nov 2:eabl9551. doi: 10.1126/science.abl9551.
    PubMed     Abstract available


    October 2021
  97. KRISHTEL P, Hassan F
    Share vaccine know-how.
    Science. 2021;374:379.
    PubMed     Abstract available


  98. ROBERTS L
    Polio vaccination to resume across Afghanistan.
    Science. 2021;374:382.
    PubMed     Abstract available


  99. CORBETT KS, Gagne M, Wagner DA, O' Connell S, et al
    Protection against SARS-CoV-2 beta variant in mRNA-1273 vaccine-boosted nonhuman primates.
    Science. 2021 Oct 21:eabl8912. doi: 10.1126/science.abl8912.
    PubMed     Abstract available


  100. VOGEL G
    WHO gives first malaria vaccine the green light.
    Science. 2021;374:245-246.
    PubMed     Abstract available


  101. GOEL RR, Painter MM, Apostolidis SA, Mathew D, et al
    mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern.
    Science. 2021 Oct 14:eabm0829. doi: 10.1126/science.abm0829.
    PubMed     Abstract available


  102. CAMPOS-MERCADE P, Meier AN, Schneider FH, Meier S, et al
    Monetary incentives increase COVID-19 vaccinations.
    Science. 2021 Oct 7:eabm0475. doi: 10.1126/science.abm0475.
    PubMed     Abstract available


  103. COHEN J
    New Chinese vaccine could bolster global arsenal.
    Science. 2021;374:12-13.
    PubMed     Abstract available


    September 2021
  104. WADMAN M
    Israel's high case plateau may offer worrisome portent.
    Science. 2021;373:1428-1429.
    PubMed     Abstract available


  105. WADMAN M
    SARS-CoV-2 infection confers greater immunity than shots.
    Science. 2021;373:1067-1068.
    PubMed     Abstract available


    August 2021
  106. PINTO D, Sauer MM, Czudnochowski N, Low JS, et al
    Broad betacoronavirus neutralization by a stem helix-specific human antibody.
    Science. 2021 Aug 3. pii: science.abj3321. doi: 10.1126/science.abj3321.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.